English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase Journal article
Shen, Junyi, Hu, Rong, Lin, Anqi, Jiang, Aimin, Tang, Bufu, Liu, Zaoqu, Cheng, Quan, Miao, Kai, Zhang, Jian, Luo, Peng. Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase[J]. eClinicalMedicine, 2024, 73, 102684.
Authors:  Shen, Junyi;  Hu, Rong;  Lin, Anqi;  Jiang, Aimin;  Tang, Bufu; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5 | Submit date：2024/07/04
Car-t  Faers  Myelodysplastic Syndromes  Second Primary Malignancy  T-cell Lymphoma  Vigibase  
Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression Journal article
Sun, Ting, Zhang, Keqiang, Li, Wendong, Liu, Yunze, Pangeni, Rajendra P., Li, Aimin, Arvanitis, Leonidas, Raz, Dan J.. Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression[J]. Cell Communication and Signaling, 2022, 20(1), 147.
Authors:  Sun, Ting;  Zhang, Keqiang;  Li, Wendong;  Liu, Yunze;  Pangeni, Rajendra P.; et al.
Favorite | TC[WOS]:12 TC[Scopus]:12  IF:8.2/8.0 | Submit date：2023/01/30
Usp22  Ap2  Atf3  Nsclc  Transcriptional Regulation  Cell Proliferation  Invasion  Malignancy  
Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors Journal article
Shuang Zhang, Shan Yu, Wenying Hou, Xiaoying Li, Chunping Ning, Yingnan Wu, Feng Zhang, Yu Fei Jiao, Leo Tsz On Lee, Litao Sun. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors[J]. JOURNAL OF OVARIAN RESEARCH, 2019, 12(1).
Authors:  Shuang Zhang;  Shan Yu;  Wenying Hou;  Xiaoying Li;  Chunping Ning; et al.
Favorite | TC[WOS]:14 TC[Scopus]:16  IF:3.8/4.2 | Submit date：2020/05/15
Borderline Ovarian Tumor  Preoperative Evaluation  Risk Of Malignancy Index  Differential Diagnosis  Benign Ovarian Tumor  
Proteome analysis and its impact on the discovery of serological tumor markers Journal article
Poon, TCW, Johnson, PJ. Proteome analysis and its impact on the discovery of serological tumor markers[J]. Clinica Chimica Acta, 2001, 313(1-2), 231-239.
Authors:  Poon, TCW;  Johnson, PJ
Favorite | TC[WOS]:57 TC[Scopus]:70  IF:3.2/3.7 | Submit date：2019/01/10
Proteom  Proteomics  Tumor Markers  Malignancy  Hepatocellular Carcinoma  Serum